Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

  • Feb 2018

As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain.

A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and prevention programs for American Indians and Alaska Natives. The SDP is currently running on partial funding, and it is imperative that Congress reauthorize a two-year spending bill for the program to ensure its future viability.

 If Congress does not renew the SDP by February 8, diabetes research and prevention programs could be seriously disrupted.  We urge all U.S. Endocrine Society members to join our efforts to protect the Special Diabetes Program. Please take a minute to participate in our online advocacy campaign for SDP.  You only need to enter EITHER your address OR your member ID and email. Our software will provide a letter and direct it to your Congressional offices for you. Your voice can help make a difference!

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

Find more in